Cargando…

Hypertonicity-Affected Genes Are Differentially Expressed in Clear Cell Renal Cell Carcinoma and Correlate with Cancer-Specific Survival

The heterogeneity of renal cell carcinoma (RCC) subtypes reflects the cell type of origin in the nephron, with consequences for therapy and prognosis. The transcriptional cues that determine segment-specific gene expression patterns are poorly understood. We recently showed that hypertonicity in the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kandabarau, Siarhei, Leiz, Janna, Krohn, Knut, Winter, Stefan, Bedke, Jens, Schwab, Matthias, Schaeffeler, Elke, Edemir, Bayram
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7017076/ https://www.ncbi.nlm.nih.gov/pubmed/31861377 http://dx.doi.org/10.3390/cancers12010006

Ejemplares similares

Characterization of Genetic Heterogeneity in Recurrent Metastases of Renal Cell Carcinoma
por: Sauter-Meyerhoff, Carolin, et al.
Publicado: (2021)

MCT4 surpasses the prognostic relevance of the ancillary protein CD147 in clear cell renal cell carcinoma
por: Fisel, Pascale, et al.
Publicado: (2015)

Clinical utility of the S3-score for molecular prediction of outcome in non-metastatic and metastatic clear cell renal cell carcinoma
por: Büttner, Florian, et al.
Publicado: (2018)

Thioredoxin 1 (Trx1) is associated with poor prognosis in clear cell renal cell carcinoma (ccRCC): an example for the crucial role of redox signaling in ccRCC
por: Ribback, Silvia, et al.
Publicado: (2021)

Nicotinamide‐N‐methyltransferase is a promising metabolic drug target for primary and metastatic clear cell renal cell carcinoma
por: Reustle, Anna, et al.
Publicado: (2022)

Dendritic Cells or Macrophages? The Microenvironment of Human Clear Cell Renal Cell Carcinoma Imprints a Mosaic Myeloid Subtype Associated with Patient Survival
por: Brech, Dorothee, et al.
Publicado: (2022)

Loss of RANBP3L leads to transformation of renal epithelial cells towards a renal clear cell carcinoma like phenotype
por: Chernyakov, Dmitry, et al.
Publicado: (2021)

A Molecularly Characterized Preclinical Platform of Subcutaneous Renal Cell Carcinoma (RCC) Patient-Derived Xenograft Models to Evaluate Novel Treatment Strategies
por: Gürgen, Dennis, et al.
Publicado: (2022)

p53 is functionally inhibited in clear cell renal cell carcinoma (ccRCC): a mechanistic and correlative investigation into genetic and molecular characteristics
por: Diesing, Karoline, et al.
Publicado: (2021)

Methylomes of renal cell lines and tumors or metastases differ significantly with impact on pharmacogenes
por: Winter, Stefan, et al.
Publicado: (2016)

Pharmacogenomics: a key component of personalized therapy
por: Schwab, Matthias, et al.
Publicado: (2012)

Integrative -omics and HLA-ligandomics analysis to identify novel drug targets for ccRCC immunotherapy
por: Reustle, Anna, et al.
Publicado: (2020)

Impact of NUDT15 genetics on severe thiopurine-related hematotoxicity in patients with European ancestry
por: Schaeffeler, Elke, et al.
Publicado: (2019)

Impact of an Altered Wnt1/β-Catenin Expression on Clinicopathology and Prognosis in Clear Cell Renal Cell Carcinoma
por: Kruck, Stephan, et al.
Publicado: (2013)

Unexpected Gallbladder Metastasis of Clear Cell Renal Carcinoma
por: White, Ian, et al.
Publicado: (2019)

Tumor-associated macrophages in clear cell renal cell carcinoma express both gastrin-releasing peptide and its receptor: a possible modulatory role of immune effectors cells
por: Bedke, Jens, et al.
Publicado: (2009)

Oncogenic MicroRNAs Characterization in Clear Cell Renal Cell Carcinoma
por: Petrozza, Vincenzo, et al.
Publicado: (2015)

Clinical and Functional Relevance of the Monocarboxylate Transporter Family in Disease Pathophysiology and Drug Therapy
por: Fisel, Pascale, et al.
Publicado: (2018)

Claudins in the Renal Collecting Duct
por: Leiz, Janna, et al.
Publicado: (2019)

Unexpected localization of AQP3 and AQP4 induced by migration of primary cultured IMCD cells
por: Rose, Ralph, et al.
Publicado: (2021)

Identification of an individualized autophagy prognostic index in clear cell renal cell carcinoma patients
por: Jin, Yi, et al.
Publicado: (2020)

A novel molecular signature identifies mixed subtypes in renal cell carcinoma with poor prognosis and independent response to immunotherapy
por: Büttner, Florian A., et al.
Publicado: (2022)

Trends in Initial Systemic Therapy for Elderly Patients with Metastatic Clear Cell Renal Cell Carcinoma
por: Osterman, Chelsea K., et al.
Publicado: (2020)

Qualitative Assessment of Contrast-Enhanced Ultrasound in Differentiating Clear Cell Renal Cell Carcinoma and Oncocytoma
por: Tufano, Antonio, et al.
Publicado: (2023)

Combinations of common SNPs of the transporter gene ABCB1 influence apparent bioavailability, but not renal elimination of oral digoxin
por: Hsin, Chih-hsuan, et al.
Publicado: (2020)

Molecular Heterogeneity Between Paired Primary and Metastatic Lesions from Clear Cell Renal Cell Carcinoma
por: Roussel, Eduard, et al.
Publicado: (2022)

Endoscopic band ligation with hypertonic glucose cushion in the treatment of ileal pouch prolapse
por: Shen, Bo
Publicado: (2020)

SDF1 Polymorphisms Influence Outcome in Patients with Symptomatic Cardiovascular Disease
por: Rath, Dominik, et al.
Publicado: (2016)

Lithium Chloride and GSK3 Inhibition Reduce Aquaporin-2 Expression in Primary Cultured Inner Medullary Collecting Duct Cells Due to Independent Mechanisms
por: Kaiser, Marc, et al.
Publicado: (2020)

C4d Deposition after Allogeneic Renal Transplantation in Rats Is Involved in Initial Apoptotic Cell Clearance
por: Reuter, Stefan, et al.
Publicado: (2021)

Variants of PEAR1 Are Associated With Outcome in Patients With ACS and Stable CAD Undergoing PCI
por: Stimpfle, Fabian, et al.
Publicado: (2018)

Platelet miRNAs: differential expression in coronary artery disease and associations with course of left ventricular systolic function
por: Goldschmied, Andreas, et al.
Publicado: (2023)

The nuclear factor of activated T cells 5 (NFAT5) contributes to the renal corticomedullary differences in gene expression
por: Chernyakov, Dmitry, et al.
Publicado: (2022)

Paraneoplastic Hypereosinophilia in Locally Advanced Clear Cell Renal Carcinoma
por: Ellez, Halil İbrahim, et al.
Publicado: (2023)

Tumour response in metastatic renal cell carcinoma treated with tyrosine kinase inhibitors – assessment of intra-tumour heterogeneity
por: Stühler, Viktoria, et al.
Publicado: (2016)

Genetics is a major determinant of expression of the human hepatic uptake transporter OATP1B1, but not of OATP1B3 and OATP2B1
por: Nies, Anne T, et al.
Publicado: (2013)

Identification of Prognostic Organic Cation and Anion Transporters in Different Cancer Entities by In Silico Analysis
por: Edemir, Bayram
Publicado: (2020)

Identification of novel differentially expressed lncRNA and mRNA transcripts in clear cell renal cell carcinoma by expression profiling
por: Deng, Mario, et al.
Publicado: (2015)

Renal protection in sepsis: Is hypertonic sodium (lactate) the solution?
por: Honore, Patrick M., et al.
Publicado: (2019)

Is a single portal venous phase in contrast-enhanced CT sufficient to detect metastases or recurrence in clear cell renal cell carcinoma? – a single-center retrospective study
por: Hagen, Florian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_o3pf8re5k9lkgkmoqbr49bi2l2